Phase i clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors

Cristiana Sessa, Gianluca Del Conte, Alexandre Christinat, Sara Cresta, Antonella Perotti, Elisa Gallerani, Pilar Lardelli, Carmen Kahatt, Vicente Alfaro, Jorge L. Iglesias, Carlos Fernández-Teruel, Luca Gianni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase i clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences